Differentiation therapy is being developed as an additional therapeutic option for the treatment of several forms of cancer, including myeloid leukemia. In model systems, the physiologically active form of vitamin D, 1, a25-dihydroxyvitamin D 3 (1,25D), induces monocytic differentiation of human myeloid cells, but the mechanism is not clear. We report here, the first direct connection between the signal provided by 1,25D and the molecular circuitry known to be involved in monocytic differentiation. Specifically, we show that 1,25D selectively increases the expression of the gene encoding kinase suppressor of Ras-1 (KSR-1) in HL60 cells, while other differentiationinducing agents such as 12-O-tetradecanoylphorbol-13-acetate, retinoic acid or dimethyl sulfoxide do not significantly increase KSR-1 expression. Further, the upregulation of KSR-1 gene by 1,25D is competed by ZK159222, an antagonist of vitamin D receptor (VDR) action, and can occur in the presence of protein synthesis inhibitor cycloheximide, showing that the effect is direct. Most importantly, we have identified a vitamin D responsive element (VDRE) in the promoter region of the human KSR-1 gene, to which VDR binds in a 1,25D-dependent manner, in vitro and in vivo. This binding is paralleled by increased association of RNA polymerase II with the transcription start site of KSR-1 gene, and the VDRE is functional in reporter assays. Our findings offer a potential mechanism for a signaling pathway that contributes to 1,25D-induced monocytic differentiation of human myeloid leukemia cells.
Introduction
Differentiation therapy has the potential to increase therapeutic options for the treatment of neoplastic diseases. In particular, all-trans retinoic acid is frequently effective as the first-line therapy when used in acute promyelocytic leukemia, by inducing differentiation of the arrested promyelocytes to the more mature granulocytes (Chomienne et al., 1990) . In vitro, derivatives of vitamin D induce monocytic differentiation of several other subtypes of myeloid leukemia (Abe et al., 1981; Studzinski et al., 1985) , but the translation of these findings to the clinic has been slow. One problem is that while several genes that mediate the classical actions of vitamin D, 1, a25-dihydroxyvitamin D 3 (1,25D) on calcium homeostasis are known to be directly regulated by 1,25D, the genes that can be clearly linked to the induction of monocytic differentiation by 1,25D have not been identified.
Cellular actions of 1,25D are mediated by the vitamin D receptor (VDR), which forms heterodimers with isoforms of retinoid X receptors (RXRs) in the presence of 1,25D. VDR/RXR heterodimers bind to cognate vitamin D response elements (VDREs) in the promoter regions of 1,25D target genes (Lin and White, 2004) . High affinity VDREs are composed of direct repeat of hexanucleotide PuG(G/T)TCA half-sites separated by 3 bp (DR3 elements). Although a VDRE has been identified in the promoter of the cell cycle regulatory gene p21
Cip1 and its role in 1,25D-induced differentiation has been suggested, its expression does not correlate with differentiation (Liu et al., 1996; Wang et al., 1996) . Thus, in the current state of knowledge it is difficult to devise mechanism-based approaches designed to dissociate the toxicity associated with the effects of therapeutic levels of 1,25D on calcium metabolism from the induction of differentiation by 1,25D.
We, and others, have previously linked the activation of the mitogen-activated protein kinases (MAPK) pathways to the initial events that lead to 1,25D-induced monocytic differentiation of human myeloid leukemia cells (Song et al., 1998; Marcinkowska, 2001; Wang and Studzinski 2001; Wang et al., 2003) . These kinases, such as ERK1/2, or their targets, such as p90 RSK , can then phosphorylate nuclear transcription factors implicated in monocytic differentiation, which include AP-1 and C/EBPb (Ji and Studzinski, 2004; Wang et al., 2005a) . For instance, a C/EBP binding element is present in the promoter of the CD14 gene, which is a major component of the mature monocytic phenotype (Pan et al., 1999) , and C/EBPb has been reported to be a downstream target of 1,25D (Christakos et al., 2003) .
Thus, there already exists a plausible scenario for the involvement of MAPK pathways in the induction of 1,25D-induced monocytic differentiation, but what initiates their activation has not been clear. Recently, we reported that an auxiliary member of the Raf-MAPK signaling pathway, kinase suppressor of Ras-1 (KSR-1) (Therrien et al., 1995; Zhang et al., 1997) , is upregulated at both mRNA and protein level in 1,25D-treated HL60 cells, and when KSR-1 upregulation is reduced by an antisense strategy differentiation of these cells is inhibited. Conversely, transfection of a fulllength KSR-1 expression construct potentiated HL60 cell differentiation induced by near-physiological levels of 1,25D (Wang and Studzinski, 2004) . However, the mechanism of the KSR-1 upregulation by 1,25D has not been known. We now show that the upstream promoter region of the KSR-1 gene contains a sequence with a functional VDRE motif, so that KSR-1 expression can potentially be targeted directly by 1,25D-activated VDR, and thus link 1,25D to the MAPK pathway activation in monocytic differentiation of HL60 cells.
Results

KSR-1 expression is selectively upregulated by 1,25D in differentiating HL60 cells
We have previously reported that KSR-1 is expressed at both mRNA and protein level in HL60 cells induced to differentiate by low, near-physiological, concentrations of 1,25D (Wang and Studzinski, 2004) , but a question can be raised whether the changes we observed in KSR expression are simply consequences of the differentiated state of the cells, or specifically induced by 1,25D. To answer this question, we induced differentiation of HL60 cells with three other well established differentiation agents and ceramide, a stress inducing agent that has also been reported to induce monocytic differentiation (Rovera et al., 1979; Bunce et al., 1983; Bielawska et al., 1992; Lamkin et al., 2006) . As shown in Figure 1 , exposure of HL60 cells to concentrations of these compounds reported to induce differentiation (Rovera et al., 1979; Bunce et al., 1983; Bielawska et al., 1992; Lamkin et al., 2006) failed to significantly upregulate KSR-1 expression, while 1,25D did produce the expected upregulation. This suggests that there may be a special link between 1,25D signaling and KSR-1 gene expression.
The expression of KSR-1 is inhibited in parallel with the inhibition of 1,25D-induced differentiation by ZK159222 (ZK), an antagonist of VDR function While it is clear that 1,25D selectively increases KSR-1 expression in differentiating HL60 cells, a role of VDR in the transmission of the signal provided by 1,25D was not previously demonstrated. We therefore investigated if ZK, a synthetic analog of 1,25D which competes with 1,25D for VDR binding, but inhibits the interaction of the liganded VDR with the transcriptional coregulators (Herdick et al., 2000) , also inhibits differentiation of HL60 cells in parallel with its inhibition of KSR-1 expression. As shown in Figure 2 , ZK significantly (Po0.05) inhibited the expression of KSR-1, similar to its inhibition of differentiation. As ZK has also weak agonist activity, there was some differentiation and modest upregulation of KSR-1 expression induced by Increased expression of KSR-1 induced by 1,25D can occur in the absence of new protein synthesis To distinguish a direct from an indirect effect of 1,25D on the transcription of the KSR-1 gene, we added a high concentration (200 mg/ml) of cycloheximide (CHX), an inhibitor of protein synthesis (Siegel and Sisler, 1963) , before the induction of differentiation with 1,25D. In this type of experiment KSR-1 mRNA levels will not increase if expression of another gene is required, whose protein product activates KSR-1 gene transcription (Lau and Nathans, 1987) . The high concentration of CHX was chosen to ensure as complete inhibition of protein synthesis as possible. In our experiments 1,25D significantly (Po0.05) induced the upregulation of KSR-1 gene expression in the presence of CHX (even at 1 mg/ml, data not shown), suggesting that the effect of 1,25D on the KSR-1 regulatory DNA element is immediate and direct ( Figure 3) .
In these experiments, we also monitored cell viability to exclude possible erroneous results that could be due to the cytotoxicity of concentrations of CHX necessary to inhibit all or most of cellular protein synthesis. That this is not a concern was demonstrated by the similar effects of CHX on KSR expression at the 6 h experimental time point, when no loss of viability was observed, as at 24 h, when there was a considerable loss of viability ( Figure 3b ).
The KSR-1 gene upstream promoter has a VDRE that binds VDR in vitro in a 1,25D-dependent manner In silico examination of the DNA sequences in the human gene revealed the presence of a candidate VDRE located at À8156 from the initiation site of KSR-1 transcription (Wang et al., 2005b) . Whereas previous promoter deletion analyses have identified VDREs in 1,25D-responsive promoters that are highly degenerate (Lin and White, 2004) , the element identified here (GGTgCAtatAGGTCA) differs from the VDRE DR3 consensus of PuG(G/T)TCAn3PuG(G/T)TCA by only Since 'supershifting' antibodies to VDR and RXR isoforms are currently not available, the identity of the proteins bound to the 'KSR-1 VDRE' was investigated by using antibodies to these proteins, which block their binding to DNA. As Figure 4d shows, the gel run longer than the standard time used for the gels shown in Figure 4a and c achieved separation of two complexes. While an irrelevant control antibody (to c-fos) and antibodies to RXRb and RXRg had no discernable effect on complex formation consistent with the minimal expression of these RXR isoforms in HL60 cells (Figure 4d, lanes 1, 4 and 5) , the anti-VDR antibody markedly blocked the formation of the more rapidly migrating complex, and to a lesser extent the formation of the upper complex ( Figure 4d, lane 2) . The anti-RXRa antibody substantially reduced the formation of the upper complex, but not of the lower, more rapidly migrating complex (Figure 4c, lane 3) . These experiments demonstrate that VDR and RXRa can bind to the 'KSR-1 VDRE', and suggest that both VDR homodimers (more rapidly migrating) and VDR-RXRa heterodimers (more slowly migrating) can bind to this DNA element.
The KSR-1 gene upstream promoter VDRE binds VDR in vivo in a 1,25D-dependent manner To determine if VDR binds to the 'KSR-1 VDRE' in intact cells we performed chromatin immunoprecipita- demonstrated that this VDRE motif did indeed bind VDR in vivo, and that treatment of the cells for 4 h with 100 nM 1,25D resulted in a more than a twofold increase in this association, whereas a control region in the genome without any apparent VDRE motif does not associate with VDR ( Figure 5, regions 1 and 3) . Further, following treatment of the cells with 1,25D a ChIP assay with an antibody to RNA polymerase II (Pol II) showed a similar twofold increase of the association of this enzyme with the transcription origin of the KSR-1 gene ( Figure 5 , region 2). These parallel 1,25D-dependent increases in the associations between VDR/VDRE and Pol II/KSR-1 transcription start site suggest the functionality of this new VDRE.
Functional validation of KSR-1 VDRE
The functionality of KSR-1 VDRE was tested by placing the À8227 to À7959 fragment of KSR-1 promoter sequence encompassing the VDRE upstream of a truncated SV40 early promoter driving expression of a luciferase reporter gene, and co-transfecting it with a VDR expression vector into COS-7 cells. VDR-and 1,25D-dependent activation (>3-fold) of promoter activity was observed in cells transfected with VDREcontaining but not with control reporter plasmids ( Figure 6 ).
Discussion
Antisense and transfection of KSR-1 approaches have previously shown that KSR-1 amplifies the monocytic differentiation signal provided by low, near physiological, concentrations of 1,25D (Wang and Studzinski, 2004) . Here, we present evidence for a direct regulation by the 1,25D-bound VDR of the KSR-1 gene, which is linked to monocytic differentiation selectively induced by 1,25D. We also identify for the first time RXRa as the predominant partner for 1,25D-induced VDR/RXR heterodimers in differentiating HL60 cells. The biological significance of finding KSR-1 to be one of 'immediate early genes' in 1,25D-induced differentiation of HL60 cells is provided by published data which strongly suggest that KSR-1 functions to activate the MAP kinase cascade, although whether by a direct phosphorylation of Raf-1 by KSR-1 (Kolesnick and Xing, 2004; Zhang et al., 1997) or by the KSR-1 protein acting as a scaffold or a platform that brings together several components of the MAPK pathway (Roy and Therrien, 2002; Ory and Morrison, 2004) , is still a matter for debate. In any case, the role of KSR-1 as a propagator of activating signals down the MAPK pathway is not questioned.
The present identification of a VDRE that can upregulate KSR-1 expression now provides a more complete chain of events in the circuitry for 1,25D signaling of monocytic differentiation, as depicted in Figure 7 . We propose that when 1,25D enters the nucleus and binds to VDR it induces a conformational change in VDR, which favors formation of a heterodimer with RXRa and then binds to various VDREs in the accessible sites in the genome. The resultant activation of transcription of these 'immediate early' A reporter plasmid containing an SV40 promoter lacking a VDRE (pGL-3/promoter) was transfected as a negative control.
Vitamin D targets KSR-1 gene X Wang et al 1,25D -response genes produces mRNAs that are translated into proteins which further signal differentiation by various means, including phosphorylating cascades such as the MAPK pathways (Wang and Studzinski, 2001; Wang et al., 2003) , and nuclear transcription factors that include AP-1 (Kolla and Studzinski, 1994; Qi et al., 2002; Wang et al., 2005a) and C/EBPs (Ji and Studzinski, 2004; Dhawan et al., 2005; Ikezoe et al., 2005; Studzinski et al., 2005) . We propose that KSR-1 acts as a scaffold (or the initial kinase) that contributes to the initiation of the MAPK cascades in response to physiological levels of 1,25D, and we provide a new link for the mechanism underlying this sequence of events. The KSR-1 VDRE-1 lies at more than 8 kb from the transcription start site of the gene, which is considerably more distal than the vast majority of VDREs characterized to date. However, most VDREs have been identified by cloning of relatively limited fragments of proximal promoter regions. More recent studies using approaches such as ChIP followed by microarray analysis (ChIP-on-chip) have identified response elements for the VDR (Fretz et al., 2006) , and other nuclear receptors (Carroll et al., 2005) lying at distances substantially greater than 10 kb from transcription start sites of target genes, confirming that nuclear receptors are capable of regulating transcription over extended regions of chromatin.
Finally, it is noteworthy that KSR-1 was also identified as a rapidly induced direct 1,25D target gene in microarray analyses of squamous carcinoma cells treated with 1,25D and CHX for 12 h (Wang et al., 2005b) , in complete agreement with our present findings. Taken together, these studies suggest that KSR-1 may also be a downstream mediator of 1,25D signaling in tissues other than differentiating monocytes.
Materials and methods
Cells and culture
The experiments were conducted using HL60 cells in suspension culture, as previously described (Wang and Studzinski, 2001; Wang et al., 2003) . The cells were exposed to 1,25D (Bioxell, Nutley, NJ, USA), 12-O-tetradecanoylphorbol-13-acetate, (Sigma, St Louis, MO, USA), all-trans retinoic acid (Sigma), dimethyl sulfoxide (Sigma) or cell permeable C 2 -ceramide (Biomol, Plymouth Meeting, PA, USA). Monocytic and granulocytic differentiation was assessed by the expression of CD14 and CD11b markers by flow cytometry, and monocytic phenotype was confirmed by cytochemical demonstration of the cytoplasmic monocyte-specific esterase (Wang and Studzinski, 2001) . Cell viability was determined by Trypan blue exclusion (Wang and Studzinski, 2001) . Each experiment was repeated at least three times.
Polymerase chain reaction
Semiquantitative measurements of KSR-1 and b-actin mRNA levels were performed as described before (Wang and Studzinski, 2004) . Briefly, total RNA was extracted using RNeasy Kit, treated with DNase I, reverse transcribed and amplified by using Eppendorf gradient mastercycler. The primer sequences used were KSR-1 upstream primer (5-agcaagtcccatgagtctca-3), downstream primer (5-caacctgcaatgcttgcact-3); b-actin, upstream primer (5-tgacggggtcacccacac tgtgcccagcta-3), and downstream primer (5-ctagaagcatttgccggtggacgatggaggg-3). The reverse transcription-polymerase chain reaction (RT-PCR) products were separated in 2% agarose gels containing ethidium bromide (1 mg/ml). The intensities of the KSR-1 and b-actin bands were measured using Image QuaNT program (Molecular Dynamics, Sunnyvale, CA, USA). Real-time PCR was carried out by using a lightcycler with Faststart DNA SYBR Green PCR kit (Roche Diagnostics, Indianapolis, IN USA). cDNA was synthesized by using 1 mg DNase I-treated total RNA. Reverse transcription conditions were as follows: 421C for 15 min, 951C for 5 min and 51C for 5 min (one cycle). Real-time PCR was performed following the protocol provided by the manufacturer. The reactions started at 951C for 7 min, followed by 40 cycles of 951C for 10 s, 551C for 10 s and 721C for 10 s. mRNA-fold changes in KSR1 target gene relative to the RNA polymerase II control were calculated by relative quantification analysis. Primers used in real-time PCR were: KSR1:
0 -gtgcggctgcttccataa-3 0 . Quality of PCR product was monitored using post-PCR melting curve analysis.
Western blot analysis
Whole-cell extracts were prepared for immunoblotting. The cells were harvested and washed twice with ice-cold 1 Â phosphate-buffered saline (PBS). The washed cell pellets were solubilized with a lysis buffer containing 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM ethylenediamine-N,N,N 0 ,N 0 -tetraacetic acid (EDTA), 1 mM ethyleneglycoltetreacetate, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1mM phenylmethylsulfonyl fluoride (PMSF), 1 mg/ml leupeptin, 1 mg/ml aprotinin, followed by centrifugation at 12 000 g for 5 min. The protein concentrations of the extracts were determined by using Bio-Rad protein assay kit. Equal amounts of 3 Â sodium dodecyl sulfate (SDS) sample buffer containing 150 mM Tris-HCl, pH 6.8, 30% glycerol, 3% SDS, 1.5 mg/ml bromophenol blue dye, and 100 mM dithiothreitol were then added to each sample. Equal amounts of whole-cell extracts (40 mg of protein) were separated on 10% SDS-polyacrylamide gel electrophoresis (PAGE) gels and transferred to nitrocellulose membranes (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The membranes were blocked with 5% milk in TBS/0.1% Tween-20 for 1 h, subsequently blotted with different primary antibodies, and then the membranes were blotted with a horseradish-linked secondary antibody for 1 h. The protein bands were visualized with a chemiluminescence assay system (Amersham). The protein loading of the gel and efficiency of the transfer were controlled by stripping the membrane and reprobing for Crk-L, a constitutively expressed protein in HL60 cells.
Electrophoretic mobility shift assays
The nuclear extracts used for gel mobility shift assays were prepared as described before (Andrews and Faller, 1991) . All steps were performed at 41C. Briefly, 10 7 cells were harvested, washed twice with PBS, and resuspended in 0.2 ml of cell extraction buffer (10 mM 2-[4-(2-hydroxyethyl)-1-piperazinyl] ethanesulfonic acid (HEPES)-potassium hydroxide (KOH), pH 7.9, 1.5 mM MgCl 2 , 10 mM KC1, 0.5 mM dithiothreitol (DTT), 0.2 mM PMSF and 10 mg/ml aprotinin). The cells were kept on ice for 10 min, vortexed for 10 s, and centrifuged at 16 000 g for 30 s. The pellet was resuspended in 30 ml of nuclear extraction buffer (20 mM HEPES-KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, and 0.2 mM PMSF and 10 mg/ml aprotinin), placed on ice for 20 min, and centrifuged at 16 000 g for 2 min. The supernatant was saved as the nuclear extract and used for gel shift assay. Double-stranded oligonucleotides from promoter regions of KSR-1 gene containing the putative VDRE (À8157 to À8180 relative to the transcription start site, ATAGTTGGTGCATATAGGT-CAGAG) and mutant VDRE (ATAGTTGAAGCATAT AGAACAGAG), were synthesized by Molecular Resource Facility of the NJ Medical School. The oligonucleotides were 5 0 -end labeled using T4 polynucleotide kinase in the presence of [g-32 P]ATP (PerkinElmer, Shelter, CT, USA). Ten mg of nuclear extracts were incubated with 50 pg (around 50 000 c.p.m.) of 32 P-labeled double-stranded oligonucleotide for 30 min at room temperature. Specificity of the VDRE binding was estimated by competition with either a 50 Â molar excess of the unlabeled double stranded VDRE nucleotide or mutant VDRE doublestranded nucleotide added to parallel samples before the incubation period. Gel shift blocking assay was performed using antibodies against VDR or RXR isoforms purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). VDR (C-20) , , are all concentrated forms suitable for gel shift analysis. The samples were separated on 6% polyacrylamide gels under nondenaturing conditions with a constant current of 22 mA, for 3 h at 41C. The gels were then dried and set up for autoradiography.
ChIP assays
ChIP assays were performed essentially as described (Wang et al., 2005b) with HL60 cell lysates immunoprecipitated with either normal rabbit IgG or anti-VDR (C-20) rabbit polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA). PCR amplifications were performed with primers: KSR-1 (À8228/À8795; region 1), 5 0 , 5 0 -gccaacagtcacatccctgg-3 0 ; 3 0 , 5 0 -tgccaactgaaaggcacctggg-3 0 ; RNA Polymerase II (À233/ þ 63; region 2), 5 0 , 5 0 -ctcagagtcctgaacctcagcag-3 0 ; 3 0 , 5 0 -ggctcaccaacaatctgacagagc-3 0 , and a negative control genomic region (À10 616/À10861; region 3) lacking a discernable VDRE: 5 0 , 5 0 -ctcagtgcttcaccttcctgct-3 0 , 3 0 : 5 0 -gcacttcagtctgtcctcct-3 0 . The intensities of each band were scanned and measured using Image QuaNT Program (Molecular Dynamics).
Recombinant plasmids KSR-1 promoter sequence between À8227/À7959 was cloned by PCR amplification of the human genomic DNA with 5 0 primer 5 0 -GCCAACAGTCACATCCCTGG-3 0 and 3 0 primer 5 0 -TGCCAACTGAAAGGCACCTGGG-3 0 . Fragments were cloned directly into PCR2.1 (Invitrogen, Burlington, Ontario, Canada), then digested with KpnI and XhoI and subcloned into luciferase promoter reporter plasmid pGL-3/promoter (Promega, Madison, WI, USA), which contains a truncated SV40 promoter lacking the 72 bp repeat enhancer, to make pGL-3/ promoter/KSR-VDRE.
Transfection and reporter assays COS-7 cells were cultured under conditions recommended by American Type Culture Collection (ATCC). Cells grown in 6-cm wells in Dulbecco's modified Eagle medium (DMEM), supplemented with 10% fetal bovine serum (FBS), were transfected in OPTI-MEM media (Invitrogen) with Lipofectamine 2000 (Invitrogen) containing 100 ng of nuclear receptor expression vector pSG5/VDR (Ferrara et al., 1994) , 1 mg of pGL-3/promoter or pGL-3/promoter/KSR-VDRE, and 100 ng of internal control vector pCMV-b-gal (Ferrara et al., 1994) . Media were replaced 5 h after transfection by DMEM supplemented with 10% FBS. After 24 h, medium was replaced by a medium containing charcoal-stripped serum and ligand (100 nM) for 24 h. Cells were harvested in 200 ml of luciferase reporter lysis buffer, and luciferase assays were performed according to the manufacturer's instructions (Promega, Madison, WI, USA).
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